Phase IIIB Subcutaneous Missed Dose Study

NCT00533897 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Abatacept
DRUG: Placebo

Sponsor

Bristol-Myers Squibb